Crossmark

Patient characteristics, disease manifestations and diagnostic findings of consecutive patients suspected of Giant Cell Arteritis (GCA) — retrospective experience from a fast-track clinic in Israel

Crossref DOI link: https://doi.org/10.1007/s10067-025-07787-0

Published Online: 2025-11-27

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haddad, Amir

Gazitt, Tal https://orcid.org/0000-0001-8612-2698
Batheesh, Ameen

Feld, Joy

Finkelstein, Naomi Yeshurun

Elias, Muna

Elhija, Muhanad Abu

Hayat, Noa

Zisman, Devy
Funding

Funding for this research was provided by:

Technion - Israel Institute of Technology
License Information

Text and Data Mining valid from 2025-11-27

Version of Record valid from 2025-11-27
More Information

Article History

Received: 29 July 2025

Revised: 27 October 2025

Accepted: 29 October 2025

First Online: 27 November 2025

Declarations

:

: This study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the research ethics committees (institutional review board) of Carmel Medical Center (CMC-0135–24). Requirement for individual patient consent forms was waived due to the retrospective, observational nature of the study.

: All authors reviewed the manuscript, helped in editing it, and approved of its publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below